ALBANY, N.Y, Oct. 15, 2020 /PRNewswire/ -- Set to chart a compound annual growth rate of 4.5% from 2018 to 2026, the global gastrointestinal bleeding treatment market is witnessing creation of a host of growth opportunities. As a result, the market worth is anticipated to improve. From USD 575.3 million in 2017, it is set to reach a valuation of USD 849.8 million by the end of the forecast period.
As per Transparency Market Research, "There are a slew of growth factors that will help the market grow. Some of the prominent trends and drivers include increasing adoption of endoscopic hemostasis as primary line of treatment and a rapidly ageing population. Additionally, it is quite interesting to note here that the incidence of re-bleeding is increasing."
Key Drivers of Growth in Global Gastrointestinal Bleeding Treatment Market:
The treatment of gastrointestinal bleeding is witnessing a notable increase in adoption of endoscopic hemostasis as primary line of treatment
An ageing population is susceptible to this and as numbers in the age group of 65 and above increase, the market is set to witness growth
Growing awareness, and efforts directed towards research and development, and improvement of medical outcomes is anticipated to contribute to growth in market
Analyze global gastrointestinal bleeding treatment market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sample of the study https://www.transparencymarketresearch.com/sample.php
Regional Analysis of Global Gastrointestinal Bleeding Treatment Market:
Growing Prevalence of gastrointestinal bleeding is set to drive the Asia Pacific (APAC) region forward over the forecast period
Revenue-wise, North America has dominated the market in the past owing to a large and growing population of people aged 60 and over
Competitive Landscape of Global Gastrointestinal Bleeding Treatment Market:
As per Transparency Market Research, the vendor landscape of global gastrointestinal bleeding treatment market is set to witness new product launches and geographic expansion as primary growth measures taken by top-tier players. There are a host of other organic and inorganic strategies that the players often deploy to consolidate their position in the market.
Prominent market players in the vendor landscape of this market include Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS plc, and US Medical Innovations, LLC, among others.
Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:
Gastrointestinal Stents Market: As per a report by Transparency Market Research, the global gastrointestinal stents market is poised to be worth US$522.8 mn by 2025 from a valuation of US$356.7 mn in 2016 expanding at a CAGR of 4.4% for the forecast period between 2017 and 2025. Among the key factors catalyzing growth of the market are increasing incidence of gastrointestinal diseases and increasing preference of patients for minimally invasive surgeries
Gastrointestinal Drugs Market: Gastrointestinal Drugs Market market is mainly being driven due to rapidly progressing interests in research activities happening in drug development-based activities all over the globe. Moreover, cases of such ailments are quite common in old-aged people, and a rising geriatric population is also increasing the demand of such drugs.
Human Microbiome Market: Companies operating in the global human microbiome market have now started to allot considerable amount of investments and funding for the activities of research and development. They are also investing heavily for the management of clinical researches and studies for new and innovative diagnostics and therapies.
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."